{"meta":{"query_hash":"115b312e199a","filters":{"venue":"Therapeutic Advances in Rare Disease"},"cohort_total":11,"direct_labels_cover":0,"predictions_cover":11,"exported":11,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/115b312e199a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Therapeutic+Advances+in+Rare+Disease"},"results":[{"id":"W4319996833","doi":"10.1177/26330040221150269","title":"Novel insights into the phenotype and long-term D-gal treatment in PGM1-CDG: a case series","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Rare Diseases Clinical Research Network","keywords":"Internal medicine; Medicine; Phenocopy; Phosphoglucomutase; Gastroenterology; Hypoglycemia; Phenotype; Endocrinology; Biology; Biochemistry; Enzyme","score_opus":0.024203659665502635,"score_gpt":0.31134956671944003,"score_spread":0.2871459070539374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319996833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718261,0.026266145,0.00003797601,0.0008013857,0.0001418141,0.0005015685,0.000008918307,0.00007688745,0.0003391998],"genre_scores_gemma":[0.9948186,0.0035567412,0.000049912145,0.0006021467,0.0000697706,0.00018529245,0.000038906226,0.000019423016,0.00065920834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991112,0.00005282387,0.00020087582,0.0002674939,0.00013858613,0.00022904681],"domain_scores_gemma":[0.9993031,0.00019040336,0.000039698025,0.00028531667,0.00002462811,0.0001568575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067583474,0.00018565997,0.00024973962,0.00014206448,0.000091603426,0.000019032133,0.000051472725,0.00003631179,0.00005597235],"category_scores_gemma":[0.00005783959,0.00011510056,0.000045827874,0.0004098144,0.0001760318,0.00020288998,0.00003073413,0.00008713159,0.000022404649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004177842,0.0010778516,0.6430159,0.0004953337,0.00015657907,0.00863097,0.014626837,0.00020806976,0.0016542084,0.0016437063,0.000013028428,0.3242997],"study_design_scores_gemma":[0.010491142,0.0008533829,0.9622372,0.0005002532,0.00039631527,0.00036540846,0.0057668956,0.002231071,0.00045531444,0.007138184,0.00902809,0.00053678866],"about_ca_topic_score_codex":0.000047443056,"about_ca_topic_score_gemma":0.0004231392,"teacher_disagreement_score":0.3237629,"about_ca_system_score_codex":0.00009618963,"about_ca_system_score_gemma":0.00010120828,"threshold_uncertainty_score":0.46936646},"labels":[],"label_agreement":null},{"id":"W4385384941","doi":"10.1177/26330040231188979","title":"The IRDiRC Chrysalis Task Force: making rare disease research attractive to companies","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Institute of Neurological Disorders and Stroke; Institut National de la Santé et de la Recherche Médicale; European Commission; Australian Government","keywords":"Task force; Task (project management); Investment (military); Disease; Public relations; Grant funding; Business; Psychology; Medicine; Political science; Marketing; Management; Economics; Pathology; Public administration","score_opus":0.03184840383005678,"score_gpt":0.4197062266891086,"score_spread":0.38785782285905185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385384941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8551292,0.1251436,0.011082393,0.0034932466,0.0010184617,0.0021309897,0.00045247673,0.00024527885,0.00130434],"genre_scores_gemma":[0.9954897,0.0028352388,0.00005587947,0.0002978465,0.00024308672,0.00027474813,0.00011078109,0.000050195446,0.0006424789],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981999,0.00014717453,0.00021339773,0.00046711534,0.00036175794,0.00061065675],"domain_scores_gemma":[0.9988096,0.00016172449,0.000034067183,0.00061550975,0.000109693625,0.00026940354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037767628,0.00020376321,0.00014484253,0.0001156524,0.000350973,0.000067665846,0.00044644915,0.000049114336,0.000012022085],"category_scores_gemma":[0.00023530883,0.00016698522,0.000096934134,0.0005134885,0.0001562262,0.000015598376,0.00024095911,0.00018518927,0.00003530291],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014123764,0.0007389478,0.043017417,0.0012992017,0.00057770795,0.0009646339,0.005600677,0.33979678,0.11153471,0.00724415,0.0089455005,0.4661565],"study_design_scores_gemma":[0.0017813625,0.00036700087,0.22149245,0.00045025974,0.000096960015,0.000006230743,0.007034938,0.0065748338,0.0076989853,0.014746674,0.7383909,0.001359394],"about_ca_topic_score_codex":0.0000036439121,"about_ca_topic_score_gemma":0.000049302787,"teacher_disagreement_score":0.7294454,"about_ca_system_score_codex":0.000041176572,"about_ca_system_score_gemma":0.000105602165,"threshold_uncertainty_score":0.68094593},"labels":[],"label_agreement":null},{"id":"W4395453307","doi":"10.1177/26330040241245725","title":"Developing a pathway to clinical trials for <i>CACNA1A</i> -related epilepsies: A patient organization perspective","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Cleveland Clinic","keywords":"Perspective (graphical); Clinical trial; Epilepsy; Psychology; Medicine; Neuroscience; Computer science; Internal medicine; Artificial intelligence","score_opus":0.13595823645103633,"score_gpt":0.43832319553801186,"score_spread":0.3023649590869755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395453307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83671093,0.025089,0.11681708,0.005487696,0.0046501406,0.00849824,0.0014121537,0.00087465456,0.0004601002],"genre_scores_gemma":[0.99351025,0.00080726173,0.00072313723,0.0041083614,0.00014450893,0.0005075659,0.0000233564,0.000082036706,0.00009350674],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959825,0.0012488771,0.0009746311,0.0010677422,0.00032536773,0.0004008657],"domain_scores_gemma":[0.9961392,0.0028199814,0.00015908176,0.0003483875,0.00022176032,0.00031153232],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062240055,0.00030723144,0.00046361686,0.00017399562,0.00014359335,0.00013197918,0.00029713588,0.00005219776,0.000065701104],"category_scores_gemma":[0.010703258,0.00026349977,0.00021002788,0.0009855814,0.0001284028,0.0003247134,0.00009052328,0.00016116179,0.00005782994],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031905686,0.0018422522,0.0039631817,0.00080986496,0.00013783327,0.00041419672,0.011315467,0.014693241,0.038624573,0.46697193,0.0005241217,0.45751277],"study_design_scores_gemma":[0.0073078675,0.0021889124,0.0070329458,0.002226333,0.00059124094,0.000023862709,0.006818509,0.009437676,0.48957872,0.30414516,0.16699834,0.003650397],"about_ca_topic_score_codex":0.0000016303369,"about_ca_topic_score_gemma":0.0000035893179,"teacher_disagreement_score":0.45386237,"about_ca_system_score_codex":0.00021622438,"about_ca_system_score_gemma":0.0005666697,"threshold_uncertainty_score":0.9999817},"labels":[],"label_agreement":null},{"id":"W4398190827","doi":"10.1177/26330040241252448","title":"Understanding patient, caregiver, and healthcare provider perspectives of the management of long-chain fatty acid oxidation disorders","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada","funders":"Ultragenyx Pharmaceutical","keywords":"Context (archaeology); Health care; Futures contract; Affect (linguistics); Medicine; Decompensation; Psychology; Nursing; Business; Internal medicine","score_opus":0.015649883581345586,"score_gpt":0.27970988985496026,"score_spread":0.2640600062736147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398190827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6138994,0.36579788,0.018472742,0.000595959,0.00022112827,0.0006350276,0.00005776155,0.000009282867,0.00031082556],"genre_scores_gemma":[0.9814596,0.018298127,0.000099429926,0.0000481232,0.000010845222,0.000026230688,0.000018672143,0.000012016949,0.00002693102],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99926305,0.000069999434,0.00015524853,0.00025777845,0.00013125718,0.00012268616],"domain_scores_gemma":[0.99964833,0.000009027666,0.000059060596,0.00022303237,0.00002115028,0.000039412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005750634,0.00010871911,0.000098610384,0.00003972753,0.00003734644,0.000008285249,0.000105205276,0.000029993975,0.000006635401],"category_scores_gemma":[0.000005854842,0.000082893726,0.00005746076,0.0001365409,0.0001791134,0.000012127496,0.0000679826,0.000041900283,1.3652685e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014829881,0.0005540988,0.09779122,0.008081088,0.00063457986,0.000016966307,0.01732992,0.0021068158,0.009192122,0.06269483,0.000049299884,0.80006605],"study_design_scores_gemma":[0.0073015797,0.0012327336,0.33761105,0.00394784,0.0011175016,0.0000092536475,0.376743,0.0018178563,0.052029237,0.19409776,0.021794882,0.0022973355],"about_ca_topic_score_codex":0.000006979218,"about_ca_topic_score_gemma":0.00006686206,"teacher_disagreement_score":0.7977687,"about_ca_system_score_codex":0.000011335855,"about_ca_system_score_gemma":0.000042136806,"threshold_uncertainty_score":0.33803082},"labels":[],"label_agreement":null},{"id":"W4401101806","doi":"10.1177/26330040241265414","title":"Koolen-de Vries Syndrome: a journey from diagnosis to treatments","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Rare Disease","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Natural history; Foundation (evidence); Translational research; Engineering ethics; Political science; Medicine; Psychology; Engineering; Pathology","score_opus":0.027493880096707987,"score_gpt":0.36227442663922244,"score_spread":0.33478054654251443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401101806","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025038135,0.993149,0.000052137184,0.00005946414,0.00042163857,0.0008194303,0.0028810971,0.00003075366,0.00008270535],"genre_scores_gemma":[0.0067156805,0.98922664,0.00011127459,0.00038963498,0.00025076003,0.0012100446,0.0015114032,0.00013234148,0.00045223616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978585,0.00016127141,0.00046381398,0.0008664539,0.00017472255,0.0004752367],"domain_scores_gemma":[0.99861515,0.000051232408,0.00013113914,0.0006989692,0.000030267096,0.00047322855],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007154707,0.0006265868,0.0008685884,0.00017115433,0.00007068209,0.0000915868,0.00052331336,0.00020853251,0.00008846444],"category_scores_gemma":[0.000052734027,0.0004952816,0.000594395,0.00024360971,0.00007565604,0.000010388694,0.00022412738,0.00018418812,0.00013986336],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012527884,0.0003258923,0.00027237777,0.0031705103,0.0006606356,0.0011170305,0.00007490389,0.0000314518,0.00000347792,0.000048378508,0.00035938073,0.99381065],"study_design_scores_gemma":[0.00023704107,0.00012309241,0.00017596997,0.0047135972,0.0019400935,0.000027091934,0.00005263956,0.0000019500449,0.0000046493437,0.0014561884,0.9906886,0.0005790516],"about_ca_topic_score_codex":0.000014380367,"about_ca_topic_score_gemma":0.000024258372,"teacher_disagreement_score":0.99323165,"about_ca_system_score_codex":0.00013962078,"about_ca_system_score_gemma":0.0005558311,"threshold_uncertainty_score":0.9997499},"labels":[],"label_agreement":null},{"id":"W4401254207","doi":"10.1177/26330040241265449","title":"The use of art as a creative research method to understand psychosocial care needs for children with rare diseases","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"Empathy and Medical Education","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Children's Health Foundation","keywords":"Psychosocial; Feeling; Reflexivity; Qualitative research; Psychology; Interpretative phenomenological analysis; Perception; Health care; Art therapy; Medicine; Clinical psychology; Developmental psychology; Psychotherapist; Medical education; Social psychology; Sociology; Social science","score_opus":0.07966007340017707,"score_gpt":0.46334414681953207,"score_spread":0.383684073419355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401254207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61189264,0.2886249,0.051188905,0.030900266,0.0010050801,0.012921536,0.0015594695,0.00027024845,0.0016369651],"genre_scores_gemma":[0.99450654,0.0012307864,0.0012972126,0.000885588,0.00027393183,0.00046131577,0.00018474401,0.000041501407,0.0011183539],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9985029,0.00020842426,0.00020323946,0.00028869556,0.00048515573,0.00031159483],"domain_scores_gemma":[0.99767846,0.0013927058,0.000034089946,0.00028977543,0.00025025007,0.00035474804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024202348,0.00014496285,0.00022001557,0.0001922508,0.00016534628,0.000045821493,0.00012476978,0.00004413502,0.000049356513],"category_scores_gemma":[0.00057503284,0.00008788344,0.000093404225,0.0007518605,0.0002909772,0.00019562567,0.000021419664,0.00021248868,0.0000055237138],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026790757,0.00092630205,0.012737075,0.0017339959,0.0005946776,0.000061960614,0.17255445,0.00026044963,0.00003404326,0.018416272,0.0047655273,0.7611245],"study_design_scores_gemma":[0.0058953767,0.0040385793,0.107887186,0.0053355256,0.0014786602,0.00001946822,0.49378532,0.00039223442,0.00033642628,0.050334096,0.32982296,0.00067416823],"about_ca_topic_score_codex":0.000020393685,"about_ca_topic_score_gemma":0.0000317306,"teacher_disagreement_score":0.7604503,"about_ca_system_score_codex":0.0001595225,"about_ca_system_score_gemma":0.0008359076,"threshold_uncertainty_score":0.35837826},"labels":[],"label_agreement":null},{"id":"W4405479939","doi":"10.1177/26330040241304440","title":"Count Me In: patient-partnered research to address disparities for rare cancer patients","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Broad Institute","keywords":"Medicine; Cancer; Outreach; Breast cancer; Family medicine; Angiosarcoma; Translational research; Cancer registry; Internal medicine; Oncology; Pathology; Political science","score_opus":0.045764032968727754,"score_gpt":0.40002393887800114,"score_spread":0.35425990590927336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405479939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82840544,0.1638787,0.00012941138,0.0029363984,0.00064224855,0.0029295813,0.00062759663,0.00009594937,0.00035469275],"genre_scores_gemma":[0.99511296,0.0015140838,0.00006446366,0.0009841871,0.00014559805,0.0015482795,0.00016273146,0.000054002663,0.00041368103],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796504,0.00010110404,0.00031871512,0.0004792128,0.00056286325,0.0005730639],"domain_scores_gemma":[0.9989968,0.00019186361,0.000024571298,0.00031257697,0.0001858356,0.00028833322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020822685,0.00020096298,0.00031491427,0.0003127641,0.00008284551,0.000052789208,0.00015752314,0.000047746707,0.00011189492],"category_scores_gemma":[0.00011244762,0.00016398593,0.00013975319,0.0005626007,0.000100945486,0.00025029236,0.00006813531,0.0002319843,0.000016325597],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010143491,0.0031665452,0.48406038,0.007487206,0.0002978376,0.0016456099,0.008004554,0.0012692881,0.00027827147,0.01075117,0.0045649484,0.4683307],"study_design_scores_gemma":[0.009241268,0.0016779747,0.24425133,0.010624052,0.00030813515,0.000008224556,0.0034324734,0.005906008,0.00088154554,0.020842329,0.70150703,0.0013196243],"about_ca_topic_score_codex":0.000056047735,"about_ca_topic_score_gemma":0.00015009964,"teacher_disagreement_score":0.6969421,"about_ca_system_score_codex":0.00025465127,"about_ca_system_score_gemma":0.0002314565,"threshold_uncertainty_score":0.6687152},"labels":[],"label_agreement":null},{"id":"W4409870204","doi":"10.1177/26330040251335660","title":"Access to drugs for rare diseases (DRD) in Canada: a comprehensive review of the provincial DRD-specific programs","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Rare Disease","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University","funders":"","keywords":"Government (linguistics); Medicine; Public administration; Political science","score_opus":0.2923756104496193,"score_gpt":0.4718568011154918,"score_spread":0.17948119066587248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409870204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039642608,0.97546744,0.00013008383,0.0035132004,0.0009908722,0.013277431,0.006419425,0.00002097045,0.00014091117],"genre_scores_gemma":[0.00021752105,0.9827747,0.00009233272,0.010116669,0.0001864699,0.006038614,0.00041253248,0.000065925415,0.00009526061],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99181277,0.00079914625,0.0054770373,0.0010443215,0.00023002684,0.00063668087],"domain_scores_gemma":[0.99311984,0.0020833262,0.0031111818,0.0012214178,0.00016185988,0.00030237998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001779989,0.0005892901,0.004145984,0.00041007987,0.00012268974,0.000060612412,0.0016232772,0.00011969703,0.00009423641],"category_scores_gemma":[0.0013885217,0.0005441783,0.0006257672,0.0011236805,0.000109653745,0.00043112302,0.0002620503,0.0003020143,0.000020161633],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007553007,0.0001970243,0.004212887,0.43067023,0.00008141519,0.0000040653385,0.00014816191,0.00005019221,7.305736e-10,0.0038371456,0.0028359666,0.5578874],"study_design_scores_gemma":[0.0004522022,0.000019667523,0.001390363,0.10542849,0.00010806341,4.5934075e-7,0.00018147532,0.000022654447,1.3629934e-8,0.0027568832,0.8891656,0.00047413283],"about_ca_topic_score_codex":0.016445847,"about_ca_topic_score_gemma":0.06208069,"teacher_disagreement_score":0.88632965,"about_ca_system_score_codex":0.0028737476,"about_ca_system_score_gemma":0.0072229137,"threshold_uncertainty_score":0.99970096},"labels":[],"label_agreement":null},{"id":"W4413838869","doi":"10.1177/26330040251369887","title":"Addressing rare diseases and access to surgical care in Brazil: a call to action","year":2025,"lang":"en","type":"editorial","venue":"Therapeutic Advances in Rare Disease","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Call to action; Action (physics); Medicine; Medical emergency; Business; Intensive care medicine; Marketing","score_opus":0.017661642257106328,"score_gpt":0.37415735379459564,"score_spread":0.3564957115374893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413838869","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1985565,0.50437325,0.00025289643,0.0008457991,0.2792624,0.004252507,0.011443299,0.000116464296,0.0008969239],"genre_scores_gemma":[0.82831305,0.022828698,0.00010823619,0.0017188695,0.13793498,0.0010826283,0.007080814,0.00018199372,0.0007506982],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974956,0.00016408521,0.00039801444,0.0011014111,0.00034504075,0.00049588236],"domain_scores_gemma":[0.9984789,0.000132276,0.000104537554,0.00057220605,0.00017425162,0.00053782406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007200655,0.00049580657,0.0004953624,0.0003096241,0.000106138184,0.00017271098,0.00057339104,0.0003560848,0.000016283791],"category_scores_gemma":[0.00030992713,0.0004903545,0.00015086039,0.00031722157,0.00007807834,0.00003281497,0.00051729585,0.00028515692,0.000002937505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03791055,0.0015876007,0.038558453,0.008200481,0.00036945395,0.0030802903,0.001116475,0.008568606,0.0007185533,0.00010517132,0.34439453,0.5553898],"study_design_scores_gemma":[0.0013686231,0.00014682235,0.0059916237,0.0007937138,0.00011249844,0.0000014051056,0.0003000229,0.0000106115085,0.00006831905,0.00016590691,0.9903633,0.00067718176],"about_ca_topic_score_codex":0.00003351429,"about_ca_topic_score_gemma":0.0006314299,"teacher_disagreement_score":0.64596874,"about_ca_system_score_codex":0.00014380594,"about_ca_system_score_gemma":0.00077779597,"threshold_uncertainty_score":0.9997548},"labels":[],"label_agreement":null},{"id":"W4414364561","doi":"10.1177/26330040251362885","title":"Gene therapy for children with X-linked myotubular myopathy: a plain language summary of publication for the ASPIRO study","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Rare Disease","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Plain language; Disease; Genetic enhancement; MEDLINE; Clinical trial","score_opus":0.01649032956457064,"score_gpt":0.31654796326965656,"score_spread":0.3000576337050859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414364561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016759349,0.97308725,0.01792365,0.000024520938,0.00006516636,0.0064576804,0.00074447284,0.000012410689,0.000008905844],"genre_scores_gemma":[0.00782648,0.9688027,0.00013116025,0.00010368765,0.00014226111,0.0027168754,0.02006703,0.00005151302,0.00015827645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864525,0.000109311,0.0004134037,0.00048144525,0.0001396092,0.00021100423],"domain_scores_gemma":[0.99881697,0.00010720431,0.00026814025,0.0006491405,0.000107779684,0.000050790262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002880933,0.00032407753,0.0005654178,0.00009260568,0.000080447,0.000018005374,0.0004224188,0.00012818191,0.000005509371],"category_scores_gemma":[0.000034258795,0.00020818782,0.00032299265,0.00019344961,0.00007486523,0.000010166222,0.000023729315,0.00009488346,1.8651075e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012365239,0.00048897346,0.00094533927,0.0025364875,0.0005017174,0.000001805239,0.00013261223,0.000029948793,0.000116622825,0.00005126294,0.000008191965,0.9939505],"study_design_scores_gemma":[0.004435949,0.0012528454,0.0018500383,0.0015681279,0.0021033501,0.000002216675,0.00029576692,0.000042279702,0.00019796811,0.00016392155,0.98736715,0.0007203681],"about_ca_topic_score_codex":0.0000046068035,"about_ca_topic_score_gemma":0.000031066254,"teacher_disagreement_score":0.99323016,"about_ca_system_score_codex":0.000018505038,"about_ca_system_score_gemma":0.00031484597,"threshold_uncertainty_score":0.8489653},"labels":[],"label_agreement":null},{"id":"W7116944718","doi":"10.1177/26330040251404519","title":"From care to cure: a patient engagement framework for rare disease and orphan drug research","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University","funders":"","keywords":"Orphan drug; Rare disease; Patient care; Disease; Health care; Healthcare system; Patient participation","score_opus":0.018489323249504336,"score_gpt":0.3645214604750581,"score_spread":0.3460321372255538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116944718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79514503,0.19425438,0.0054131867,0.001323727,0.00037845256,0.0018330334,0.0015306412,0.000022630491,0.000098887096],"genre_scores_gemma":[0.99237657,0.0026740518,0.0015459068,0.0016608003,0.00018697641,0.00081812555,0.00058576063,0.000033568445,0.000118217424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982062,0.00019644259,0.00024073625,0.000723777,0.00020724785,0.00042557466],"domain_scores_gemma":[0.99860615,0.00014365562,0.000044404915,0.00060481206,0.00018020731,0.0004207919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013502185,0.0002365825,0.00018813723,0.0001272398,0.00024341165,0.000062898645,0.0003067099,0.00006451651,0.000024600435],"category_scores_gemma":[0.00023910009,0.00022205338,0.00010707363,0.0002107544,0.00011190025,0.00001186776,0.00030746328,0.00014711893,0.0000035634434],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03084245,0.0025805414,0.07541568,0.0029148234,0.0007823072,0.00042529978,0.012457809,0.0049731173,0.006407498,0.024373287,0.007725984,0.8311012],"study_design_scores_gemma":[0.0030770523,0.00048330962,0.026749445,0.0010489341,0.00030805168,4.876732e-7,0.017408095,0.00023526499,0.0036191687,0.1732038,0.772669,0.0011973513],"about_ca_topic_score_codex":0.00001438809,"about_ca_topic_score_gemma":0.000034513458,"teacher_disagreement_score":0.82990384,"about_ca_system_score_codex":0.00005753795,"about_ca_system_score_gemma":0.0002775313,"threshold_uncertainty_score":0.9055074},"labels":[],"label_agreement":null}]}